Hannover Rück SE

TickerHNR1.XETRA
Current Price
Hannover Rück SE – stock chart

5-year stock timeline

Hannover Rück's share has transformed over the last five years from a solid but cyclical reinsurer into a defensive compounder with structurally higher earnings power, reaching 257.8 EUR as of March 2, 2026. The journey reflects COVID-era volatility, hardening reinsurance markets following catastrophe losses, and a rerating driven by strong capital, earnings upgrades, and supportive pricing across property-casualty and life reinsurance.

2019–2020: Pre-COVID stability, then shock and recovery

In 2019, Hannover Rück operated in a relatively benign environment with solid catastrophe experience and stable premium growth, positioning itself as a quality, yield-oriented reinsurer. COVID-19 in early 2020 triggered substantial loss provisions from event cancellations, mortality, and business interruption claims, sparking a sharp market sell-off in global equities and financials. The stock drawdown proved swift, but recovery followed quickly as investors looked ahead to higher future pricing in reinsurance.

Through late 2020, management emphasized capital resilience, disciplined underwriting, and the opportunity to deploy capacity at improving terms in 2021 renewals. The narrative shifted from "earnings hit from COVID" to "positioned to benefit from a hardening market." Technically, the stock traced a violent V-shaped correction and rebound, with the COVID low marking a key long-term support level that would not be revisited in subsequent years.

2021–2022: Hardening market, catastrophe pressure, range-bound trading

In 2021, strong rate increases in property-catastrophe and specialty lines, combined with solid life and health performance, supported rising premiums and improved profitability expectations. Elevated natural catastrophe losses—European floods and US storms among them—periodically pressured quarterly results.

Investors increasingly viewed Hannover Rück as a disciplined core holding in European financials, though near-term earnings volatility from catastrophes and pandemic-related life claims kept sentiment balanced between "defensive compounder" and "cat-exposed cyclical." The stock spent much of 2021–2022 in a broad sideways range with several failed breakout attempts. Rallies on strong renewal seasons and reassuring capital messages were often capped by fresh large loss news or macro shocks such as inflation and interest-rate repricing in 2022.

Rising interest rates improved reinvestment yields on the bond portfolio and supported long-term earnings and valuation arguments, helping downside hold above prior COVID lows despite periodic drawdowns tied to sector risk-off moves.

2023: Repricing, capital strength, rerating emerges

By 2023, multiple years of hardening reinsurance pricing, higher interest rates, and tighter terms and conditions were firmly embedded, creating expectations of structurally higher return on equity and stronger earnings durability. S&P affirmed Hannover Rück's AA− issuer and financial strength ratings with a stable outlook in June 2023, highlighting "very strong" capital and earnings and reinforcing the market's view of the company as one of the safest global reinsurers.

Investor perception shifted toward "high-quality, defensive compounder" rather than a simple catastrophe trade, with greater focus on consistent book value growth, dividends, and potential for special distributions from excess capital. On the chart, the share began breaking out above its prior multi-year range, establishing higher highs and higher lows as each major renewal season and set of results confirmed the improved profitability environment.

2024: Earnings upgrades and strong momentum

In 2024, Hannover Rück delivered very strong financial performance. Nine-month 2024 net income exceeded EUR 1.8 billion, aided by a positive tax one-off, and management raised full-year guidance from around EUR 2.1 billion to roughly EUR 2.3 billion. Full-year 2024 results and March 2025 earnings call commentary emphasized that 2024 was "another successful year" with a further strengthened balance sheet and a still-supportive market environment, reinforcing confidence in elevated, sustainable earnings levels.

Investor narratives centered on Hannover Rück as a capital-disciplined beneficiary of a structurally improved reinsurance cycle, with rising interest in its role as a low-volatility way to play higher rates and tight capacity in cat and specialty markets. Technically, 2024 featured a strong uptrend with only brief consolidations. The stock advanced from prior breakout levels into new all-time highs, with shallow pullbacks being bought as the market priced in higher ROE and ongoing capital returns.

Late 2024–early 2026: High plateau, supportive outlook, elevated valuation

In late 2024 and into 2025, Hannover Rück continued to signal attractive conditions in key renewal rounds. Communications in early 2025 and the January 1, 2026 renewal update pointed to sustained favorable pricing and terms in both property-catastrophe and other lines. External commentary described the sector as being on a favorable "path" due to disciplined capacity, higher rates, and improved risk selection, with Hannover Rück often cited as a prime example of a well-positioned global reinsurer.

Against this backdrop, investors largely treated the stock as a premium-rated, defensive compounder with modest cyclical risk, so the narrative focused more on capital deployment and growth options than on balance-sheet stress. From late 2024 through early 2026, the stock ground higher within an established uptrend, punctuated by short consolidations near prior highs as it moved into the mid-200s and reached 257.8 EUR by March 2, 2026, reflecting the market's confidence in the elevated earnings and capital profile.

Key risks and downside factors

HNR1.XETRA is Hannover Rück SE, one of the world's largest reinsurance groups. They operate in a tight market, writing property & casualty and life & health reinsurance across the globe. The space is dominated by a handful of well-capitalized players—Munich Re, Swiss Re, SCOR among them—all offering similar multi-line solutions to the same clients. What matters for the business: natural catastrophe exposure and man-made loss events can move the needle significantly. Reinsurance pricing cycles through periods of abundance and scarcity, which affects margins. Regulators keep tightening capital requirements. And the investment portfolio—which funds claims and generates returns—swings with market volatility, directly impacting solvency and underwriting results.

  • The company carries substantial exposure to major natural disasters and man-made loss events, which tend to create earnings swings and pressure capital reserves during severe years.
  • Intense competition and cyclical pricing in global reinsurance markets can pressure margins when underwriting discipline weakens during soft cycles.
  • Regulatory and rating-agency capital requirements—including Solvency II and underlying model assumptions—could increase required capital levels or limit growth opportunities if the company's risk profile shifts or market conditions deteriorate.
  • Market and credit risk in the investment portfolio could affect investment income, fair values, and solvency ratios through interest-rate movements, credit spreads, and equity market declines.

Competitive landscape

Hannover Rück SE is one of the world's largest reinsurers, holding its ground against major European and international competitors across property & casualty and life & health insurance. The business is inherently cyclical and exposed to catastrophic events, where success hinges on disciplined underwriting, solid capital reserves, and thoughtful risk diversification. Competition is intensifying, regulations keep shifting, and climate-driven losses are reshaping both what the company can grow into and what it needs to watch for.

Private competitors

  • Lloyd’s reinsurance market participants

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Performance Figures of Hannover Rück SE

in EUR

1M High / Low
258.20 / 240.40
52W High / Low
292.60 / 233.00
5Y High / Low
292.60 / 131.35
1M
+7.96%
3M
+0.55%
6M
+5.48%
1Y
+1.29%
3Y
+47.42%
5Y
+88.28%

Relative Performance vs Benchmarks

PeriodHannover Rück SE vs DAX vs S&P 500 (SPY)
1M +7.96% +7.56% +8.77%
3M +0.55% -3.36% -0.46%
6M +5.48% +1.06% -1.76%
1Y +1.29% -7.96% -15.59%
3Y +47.42% -10.73% -29.24%
5Y +88.28% +13.29% -4.50%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current11.11.2287,323,256,000,000,000.05.4
1Y ago13.21.22.65.4
3Y ago13.40.92.74.3
5Y ago19.20.71.55.2

Key Metrics

Market Capitalization
31.09B EUR
P/E Ratio
12.59
Analyst Target Price

Valuation Metrics

P/S Ratio
1.10
P/B Ratio
2.59

Profitability Metrics

Profit Margin
8.71%
Operating Margin
15.80%
Return on Equity
20.55%
Return on Assets
3.83%

Growth Metrics

Revenue Growth
Earnings Growth

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20259.00 EUR3.13%4.12%
20247.20 EUR3.09%
20236.00 EUR3.12%
20225.75 EUR3.89%
20214.50 EUR2.92%
20205.50 EUR3.77%
20195.25 EUR3.89%
20185.00 EUR4.22%
20175.00 EUR4.37%
20164.75 EUR4.70%
20154.25 EUR4.76%
20143.00 EUR4.41%
20133.40 EUR5.40%
20122.10 EUR4.47%
20112.30 EUR5.66%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

66.7%
Beat estimate
26.7%
Miss estimate
+30.41%
Avg surprise when beat
-15.79%
Avg surprise when miss

Reports analyzed: 60

Upcoming earnings report

March 12, 2026
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2026
Consensus22.92
Range22.05 – 24.12
9 analysts
Est. growth vs prior: 7.66%
Revisions: 7d ↑0 ↓0 · 30d ↑0 ↓3
Next quarter
March 31, 2026
Consensus6.06
Range6.06 – 6.06
1 analysts
Est. growth vs prior: 52.2%

Key financial figures

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue26.80B2.66B21.98B1.39B26.28B
Operating income (EBIT)26.80B3.21B1.85B1.47B1.73B
Net income2.64B2.33B1.82B780.80M1.23B
Free cash flow5.68B5.79B5.16B4.60B
Total assets72.13B65.67B62.96B82.90B
Equity11.79B10.13B9.06B11.89B
Net debt3.42B3.82B4.19B3.02B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon